Skip to main content

Table 2 Clinical and biochemical characteristics of the general study cohorts

From: Association between 28 single nucleotide polymorphisms and type 2 diabetes mellitus in the Kazakh population: a case-control study

  Control subjects Type 2 diabetic patients P-value
N 928 408  
Male,% (n) 27.7% (257) 44.6% (182) <10−5
Age, years 32 (18–61) 59 (29–84) <10−5
Weight, kg 63 (40–147) 80 (46–135) <10−5
Height, cm 165 (140–197) 165 (148–188) 0.154
BMI, kg/m2 23.0 (15.1–54.0) 29.3 (18.2–47.6) <10−5
Systolic blood pressure, mm Hg 110 (60–150) 130 (100–220) <10−5
Diastolic blood pressure, mm Hg 70 (50–100) 80 (60–130) <10−5
Waist circumference, cm 80 (48–180) 94 (60–160) <10−5
Hip circumference, cm - 100 (62–165) -
Waist/hip ratio - 0.95 (0.54–1.83) -
Glucose, mmol/L 4.9 (3.2–7.8) 9.6 (3.6–30.5) <10−5
Cholesterol, mmol/L 4.2 (2.0–11.8) 5.2 (2.1–16.7) <10−5
Triglycerides, mmol/L 1.0 (0.2–6.5) 1.8 (0.2–17.6) <10−5
Low-density lipoproteins, mmol/L 3.88 (1.05–15.5) 4.775 (0.23–8.67) <10−5
High-density lipoproteins, mmol/L 1.32 (0.59–2.8) 1.27 (0.6–3.6) 0.001
HbA1c, % 5.4 (4.0–7.3) 7.6 (4.4–16.4) <10−5
Insulin, μIU/mL - 12.10 (0.02–97.0) -
C-peptide, ng/mL - 4.20 (0.08–36.30) -
  1. Data are expressed as median (range) unless otherwise specified